Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-05
1998-06-23
Sayala, Chhaya D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514211, 514 50, 514456, 514731, 514736, 424649, A61K 31545, A61K 3155, A61K 3170, A61K 3135
Patent
active
057705933
ABSTRACT:
The present invention provides a pharmaceutical combination preparation, wherein it contains at least two active materials, the first active material being an inhibitor of protein kinase C and the other active material having an anti-neoplastic action, as well as pharmacologically acceptable carriers and adjuvants.
REFERENCES:
O'Brian et al., J. Natl. Cancer Inst., vol. 80(20), pp. 1628-1633, 1988 (abstract).
Hannun et al, J. Biol. Chem., vol. 263 (11), pp. 5124-5133, 1988. (abstract).
Satyamoorthy et al., Proc. Am Assoc. Cancer Res. Anau. Mect, vol. 30 (0), p. 216, 1989.
Chemical Abstracts, Band 94, 1981, Seite 62 Zusammenfassung Nr. 114601t, Columbus, Ohio, US; M. Sluyser Et Al.: "Combined endocrine therapy and chemotherapy of mouse mammary tumors", & Eur. J. Cancer 1981, 17(2), 155-9 *Zusammenfassung*.
Chemical Abstracts, Band 100, 1984, Seite 33, Zusammenfassung Nr. 132230t, Columbus, Ohio, US; C. Benz et al.: "tamoxifen and 5-fluorouracil in breast cancer: cytotoxic synergism in vitro", & Cancer Res. 1983, 43(11), 298-303 *Zusammenfassung*.
Chemical Abstract, Band 105, 1986 Seite 25 Zusammenfassung Nr. 202832v, Columbus, Ohio, US; V.V. Fomina et al.: "New ways to improve the efficacy of tamoxifen in the treatment of mammary cancer", & Izv. Akad. Nauk Kaz. SSR, Ser Biol. 1986, (4) 67-70 *Zusammenfassung*.
Chemical Abstracts, Band 98, 1983, Seite 34, Zusammenfassung Nr. 119268G, Columbus, Ohio, US; L.D. Morris et al.: "Adjuvant treatment with adramycin, methotrexate and tamoxifen of DMBA induced tumors in the rat", & IRCS Med. Sci.: Libr. Compend. 1982, 10 (12), 1045 *Zusammenfassung*.
Dialog 07028115, Medline 89330115; J. Hofmann: "Syneroistic annancement of the antioroliferative activity of cois-diamminedichlorplatinum (II) by the ether lipid analogue BM41440, aninhibitor if protein kinase C", & Lipids Apr. 1989, Band 24, Nr. 4, Seiten 312-317 *Insgesamt*.
Chemical Abstracts, Band 109, 1988, Seite 29, Zusammenfassung Nr. 204527f, Columbus, Ohio, US; J. Hofman et al.: "Enhancement of the antiproliferative effect of cis-diamminedichloroplatinum(II) and nitrogen mustard by inhibitors of protein kinase C", & Int. J. Cancer 1988, 42(3), 382-8 *Zusammenfassung*.
Sluyser et al. "Combined Endocrine Therapy and Chemotherapy of Mouse Mammary Tumors", vol. 17, p. 155 Eur. J. Cancer, 1981.
Benz et al. "Tamoxifen and 5-Fluorouracil in Breast Cancer: Cytotoxic Synergism In Vitro" vol. 43, p. 5293 Cancer Res., 1983.
Fomina et al. "New Ways to Improve the Efficacy of Tamoxifen in the Treatment of Mammary Cancer", vol. 4, p. 67 Izv. Akad. Nauk. Kaz. SSR, Ser. Biol., 1986.
Morris et al. "Adjuvant Treatment with Adriamycin, Methotrexate and Tamoxifen of DMBA Induced Tumors in the Rat" vol. 10 page 1045t. IRCS Med. Sci.: Libr. Compend., 1982.
Hofmann et al. "Synergistic Enhancement of the Antiproliferative Activity of cis-Diamminedichloroplatinum(II) by the Ether Lipid Analogue BM 41.440, an Inhibitor of Protein Kinase C", vol. 24, p. 312 Lipids, 1989.
Hofmann et al. "Enhancement of the Antiproliferative Effect of cis-Ciamminedichloroplatinium(II) and Nitrogen Mustard by Inhibitors of Protein Kinase C" vol. 42, p. 382 Int. J. Cancer, 1988.
Palayoor et al. "Inhibition of Protein Kinase C by Antineoplastic Agents: Implications for Drug Resistance", vol. 148, p. 718 Biochem. Biophys. Res. Commun., 1987.
Ido et al. "An Inhibitor of Protein Kinase C, 1-(5-Isoquinolinylsulfonyl)-2-Methylpiperazine (H-7) Inhibits TPA-Induced Reduction of Vincristine Uptake from P388 Murine Leukemic Cell", vol. 10, p. 1063 Leukemia Res., 1986.
Laubenstein et al. "Treatment of Epidemic Kaposi's Sarcoma with Etoposide or a Combination of Doxorubicin, Bleomycin and Vinblastine", vol. 2, p. 1115 J. Clin. Oncol., 1984.
Kaplan et al. "Treatment of Kaposi's Sarcoma in Acquired Immunodeficiency Syndrome with an Alternating Vincristine-Vinblastine Regimen", vol. 70, p. 1121 Cancer Treat. Rep., 1986.
Giaccone et al. "Mitomycin C, Vinblastine and cis-platin. An Active Regimen for Advanced Non-Small Cell Lung Cancer", vol. 56, p. 475 Brit. J. Cancer, 1987.
Olweny et al. "Treatment of Kaposi's Sarcoma by Combination of Actinomycin-D, Vincristine and Imidazole Carboxamide (NSC-45388): Results of a Randomized Clinical Trial", vol. 14, p. 649 Int. J. Cancer, 1974.
Nathanson et al. "Vinblastine, Infusion, Bleomycin and cis-Dichlorodiammine-Platinum Chemotherapy in Metastic Melanoma", vol. 48, p. 1290 Cancer, 1981.
Chahinian et al. "MACC(Methotrexate, Adriamycin, Cyclophosphamide and CCNU) in Advanced Lung Cancer", vol. 43, p. 1590 Cancer, 1979.
Buyukpamakcu et al. "Combined Chemotherapy in 76 Children with Non-Hodgkin's Lymphoma Excluding Burkitt's Lymphoma", vol. 56, p. 625 Br. J. Cancer, 1987.
Corbett et al. "Biology and Therapeutic Response of Mouse Mammary Adenocarcinoma (16/C) and its Potential as a Model for Surgical Adjuvant Chemotherapy" vol. 62, p. 1471 Cancer Treat. Rep., 1978.
Wallach et al. "Chemotherapy of Recurrent Ovarian Carcinoma with cis-Dichlorodiammine Platinum II and Adriamycin" vol. 55, p. 371 Obstet. Gynecol., 1980.
Anderson et al. "Childhood Non-Hodgkin's Lymphoma. The Results of Randomized Therapeutic Trial Comparing a 4-Drug Regimen (COMP) with a 10-Drug Regimen (LSA.sub.2 -L.sub.2)", vol. 308, p. 559 New Eng. J. Med., 1983.
Vogel et al. "Treatment of Kaposi's Sarcoma with a Combination of Actinomycin D and Vincristine", vol. 31, p. 1382 Cancer, 1973.
Cohen et al. "Combination Chemotherapy of Malignant Melanoma with Imidazole Carboxamide, BCNU and Vincristine", vol. 39, p. 41 Cancer, 1977.
Bailey et al. "Chemotherapy of Human Breast-Carcinoma Xenografts", vol. 42, p. 530 Br. J. Cancer, 1980.
DeWasch et al. "Combination Chemotherapy with Three Marginally Effective Agents, CCNU, Vincristine and Bleomycin, in the Treatment of Stage III Melanoma", vol. 60, p. 1273 Cancer Treat. Rep., 1976.
Holland et al. "Cisplatin Therapy of Ovarian Cancer", pp. 383-391 in Cisplatin, 1980, Academic Press.
Nathanson et al. "Pilot Study of Vinblastine and Bleomycin Combinations in the Treatment of Metastatic Melanoma", vol. 64, p. 133 Cancer Treat. Rep., 1980.
Schulman et al. "Phase II Trial of Mitomycin, Vinblastine and Cisplatin (MVP) in Non-Small Cell Bronchogenic Carcinoma" vol. 67, p. 943 Cancer Treat. Rep., 1983.
Mabel et al. "Combination Chemotherapy Against B16 Melanoma: Bleomycin/Vinblastine, Bleomycin/Cis-Diamminedichloroplatinium, 5-Fluorouracil/BCNU and 5-Fluorouracil/Methyl-CCNU", vol. 42, p. 1711 Cancer, 1978.
Samuels et al. "Bleomycin Combination Chemotherapy in the Management of Testicular Neoplasias", vol. 36, p. 318 Int. J. Cancer, 1975.
Ettinger et al. "Adriamycin (ADR) and Cis-Diamminedichloroplatinum (DDP) as Adjuvant Therapy in Osteosarcoma of the Extremities" abstract C-292 Proc. Amer. Assoc. Cancer Res. and ASCO, 1980.
Pendergrass et al. "Intensive Timed Sequential Combination Chemotherapy and Adjunctive Radiotherapy in Extensive Stage Small Cell Carcinoma of the Lung (SCC)", abstract C-505 Proc. Amer. Assoc. Cancer Res. and ASCO, 1980.
Mason et al. "Mitomycin (M), Vinblastine (V) and Cisplatin (P) Combination Chemotherapy in Non-Small Cell Lung Cancer (NSCLC)", abstract C-507 Proc. Amer. Assoc. Cancer Res. and ASCO, 1980.
Livingston et al. "BACON (Bleomycin, Adriamycin, CCNU, Oncovin and Nitrogen Mustard) in Squamous Lung Cancer" vol. 37, p. 1237 Cancer, 1976.
Vogl et al. "Combination Chemotherapy with Adriamycin and Cis-Diamminedichloroplatinum in Patients with Neoplastic Diseases", vol. 38, p. 21 Cancer, 1976.
Bitran et al. "Cyclophosphamide, Adriamycin, Methotrexate and Procarbazine (CAMP)-Effective Four-Drug Combination Chemotherapy for Metastatic Non-Oat Cell Bronchogenic Carcinoma", vol. 60, p. 1225 Cancer Treat. Rep., 1976.
Okazaki et al. "Staurosporine, a Novel Protein Kinase Inhibitor, Enhances HL-60-cell Differentiation Induced by Various Compounds", vol. 16, p. 42 Exp. Hematol., 1988.
Britell et al. "cis-Dichlorodiammineplatinum(II) Alone Followed by Adriamycin Plus Cyclophosphamide at Progression Versus cis-Dichlorodiammineplatinum(II), Adriamycin and Cyclophosphamide for Adenocarcinoma of t
Bosies Elmar
Grunicke Hans Hermann
Herrmann Dieter
Hofmann Johann
Boehringer Mannheim GmbH
Sayala Chhaya D.
LandOfFree
Method of determining a pharmaceutical combination preparations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of determining a pharmaceutical combination preparations , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of determining a pharmaceutical combination preparations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1394936